市場調查報告書

製酸藥的全球市場:各藥物類別、製劑,及各地區預測

Antacid Market Size study, by Drug Class (Proton Pump Inhibitor, H2 Antagonist, And Acid Neutralizers), by Formulation (Tablet, Liquid, And Powder) and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 914531
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
製酸藥的全球市場:各藥物類別、製劑,及各地區預測 Antacid Market Size study, by Drug Class (Proton Pump Inhibitor, H2 Antagonist, And Acid Neutralizers), by Formulation (Tablet, Liquid, And Powder) and Regional Forecasts 2019-2026
出版日期: 2019年04月01日內容資訊: 英文
簡介

本報告提供全球製酸藥市場的相關調查,市場機會,成長要素及課題,各藥物類別、製劑、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 市場估計及預測:全體/各市場區隔
    • 各地區
    • 各類藥物
    • 各製劑
  • 主要趨勢
  • 估計方法
  • 調查的前提條件

第2章 市場定義、範圍

  • 調查的目的
  • 市場定義、範圍
    • 調查範圍
    • 產業的演進
  • 調查考慮年份
  • 匯率

第3章 市場動態

  • 市場影響分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業內的競爭
    • 波特的五力分析的未來方法
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術性
  • 投資採用模式
  • 分析師的建議、結論

第5章 市場分析:各類藥物

  • 市場概述
  • 市場成果:潛在力分析
  • 市場估計、預測
  • 子區隔分析
    • H2拮抗劑
    • 質子幫浦抑制劑
    • 酸中和劑

第6章 市場分析:各製劑

  • 市場概述
  • 市場成果:潛在力分析
  • 市場估計、預測
  • 子區隔分析
    • 錠劑
    • 液體
    • 粉末

第7章 市場分析:地區

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 南美
    • 巴西
    • 墨西哥
  • 其他

第8章 競爭情形

  • 主要企業的市場策略
  • 企業簡介
    • GlaxoSmithKline plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Sanofi
    • Pfizer Inc.
    • Abbott Laboratories
    • Dabur India Ltd.
    • GlaxoSmithKline plc
    • Sun Pharmaceuticals Ltd.
    • Procter & Gamble
    • Piramal Enterprises

第9章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 調查屬性
  • 調查的前提條件
目錄

Antacid Market is valued approximately USD 6.13 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 3.9% over the forecast period 2019-2026. The growingincrease prevalence of gastric diseases has led the healthcare and pharmaceuticals providers towards the development of more enhanced gastric solution to get relief from acidity and heartburns. Antacids are the class of drugs thatwhich reduces gastric acidity resulting in the increase pH of the stomach and duodenum. The growing prevalence of gastric diseases among geriatric population has led to the increase in demand for antacids. The advancement of e-commerce industry coupled with the consumer preference for online medication due to ease of availability of drugs and home delivery services has propelled the demand for antacids. The increasing adoption of self-medication and ease of availability of various over-the-counter antacids has increased the market share of antacids. Moreover, the population of Gastroesophageal reflux disease, or GERD, has increased significantly resulting in the growingincreased demand for antacids. The various factors leading to the gastric diseases are unhealthy diet, lack of proper sleep, and lack of physical activities. This hasve resulted in the accelerated market share of antacids.

The regional analysis of Antacid market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific region is expected to register considerable growth over the forecast period owing to consumer awareness, rising investment by market players and growing disposable income have increased the market share of antacids. Moreover, availability of effective treatment methods has fostered the demand for antacids.

Major market player included in this report are:

  • GlaxoSmithKline plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • Pfizer Inc.
  • Abbott Laboratories
  • Dabur India Ltd.
  • GlaxoSmithKline plc
  • Sun Pharmaceuticals Ltd.
  • Procter & Gamble
  • Piramal Enterprises

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

  • H2 Antagonist
  • Proton pump inhibitors
  • Acid neutralizers

By Formulation:

  • Tablet
  • Liquid
  • Powder

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Antacid Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Antacid Market, by Region, 2017-2026 (USD Billion)
    • 1.2.2. Antacid Market, by Drug Class, 2017-2026 (USD Billion)
    • 1.2.3. Antacid Market, by Formulation, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Antacid Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Antacid Market Dynamics

  • 3.1. Antacid Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Antacid Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Antacid Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Antacid Market by Drug Class, Performance - Potential Analysis
  • 5.3. Antacid Market Estimates & Forecasts by Drug Class 2016-2026 (USD Billion)
  • 5.4. Polymer Emulsion Market, Sub Segment Analysis
    • 5.4.1. H2 Antagonist
    • 5.4.2. Proton pump inhibitors
    • 5.4.3. Acid neutralizers

Chapter 6. Antacid Market, by Formulation

  • 6.1. Market Snapshot
  • 6.2. Antacid Market by Formulation, Performance - Potential Analysis
  • 6.3. Antacid Market Estimates & Forecasts by Formulation 2016-2026 (USD Billion)
  • 6.4. Polymer Emulsion Market, Sub Segment Analysis
    • 6.4.1. Tablet
    • 6.4.2. Liquid
    • 6.4.3. Powder

Chapter 7. Antacid Market, Regional Analysis

  • 7.1. Antacid Market, Regional Market Snapshot
  • 7.2. North America Antacid Market
    • 7.2.1. U.S. Antacid Market
      • 7.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. Formulation breakdown estimates & forecasts, 2016-2026
    • 7.2.2. Canada Antacid Market
  • 7.3. Europe Antacid Market Snapshot
    • 7.3.1. U.K. Antacid Market
    • 7.3.2. Rest of Europe Antacid Market
  • 7.4. Asia-Pacific Antacid Market Snapshot
    • 7.4.1. China Antacid Market
    • 7.4.2. India Antacid Market
    • 7.4.3. Japan Antacid Market
    • 7.4.4. Rest of Asia Pacific Antacid Market
  • 7.5. Latin America Antacid Market Snapshot
    • 7.5.1. Brazil Antacid Market
    • 7.5.2. Mexico Antacid Market
  • 7.6. Rest of The World Antacid Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. GlaxoSmithKline plc
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Bayer AG
    • 8.2.3. Boehringer Ingelheim International GmbH
    • 8.2.4. Sanofi
    • 8.2.5. Pfizer Inc.
    • 8.2.6. Abbott Laboratories
    • 8.2.7. Dabur India Ltd.
    • 8.2.8. GlaxoSmithKline plc
    • 8.2.9. Sun Pharmaceuticals Ltd.
    • 8.2.10. Procter & Gamble
    • 8.2.11. Piramal Enterprises

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF ANTACID MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF ANTACID MARKET
  • TABLE 3. ANTACID MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. ANTACID MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. ANTACID MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD BILLION)
  • TABLE 8. ANTACID MARKET ESTIMATES & FORECASTS BY FORMULATION 2016-2026 (USD BILLION)
  • TABLE 9. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. U.S. ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 21. U.S. ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. CANADA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. CANADA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 24. CANADA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. UK ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. UK ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 27. UK ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. GERMANY ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. ROE ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. ROE ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. ROE ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. CHINA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. CHINA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. CHINA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. INDIA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. INDIA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. INDIA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. JAPAN ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. MEXICO ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. ROLA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. ROLA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. ROLA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROW ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. ROW ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. ROW ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. ANTACID MARKET, RESEARCH METHODOLOGY
  • FIG 2. ANTACID MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. ANTACID MARKET, KEY TRENDS 2018
  • FIG 5. ANTACID MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. ANTACID MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. ANTACID MARKET, PEST ANALYSIS
  • FIG 8. ANTACID MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. ANTACID MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA ANTACID MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE ANTACID MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC ANTACID MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA ANTACID MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. ANTACID MARKET, COMPANY MARKET SHARE ANALYSIS (2018)